C12N 2795/00011
Details
C12N2795/00011 (Details) appears on 1,084 US grants and 1,653 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,084
- Published applications
- 1,653
- Assignees
- 707
- Inventors
- 2,717
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 7 | 0 |
| 1994 | 4 | 0 |
| 1995 | 8 | 0 |
| 1996 | 15 | 0 |
| 1997 | 20 | 0 |
| 1998 | 24 | 0 |
| 1999 | 15 | 0 |
| 2000 | 20 | 0 |
| 2001 | 22 | 6 |
| 2002 | 25 | 22 |
| 2003 | 11 | 38 |
| 2004 | 13 | 42 |
| 2005 | 13 | 31 |
| 2006 | 18 | 25 |
| 2007 | 11 | 35 |
| 2008 | 16 | 31 |
| 2009 | 24 | 38 |
| 2010 | 17 | 62 |
| 2011 | 21 | 64 |
| 2012 | 31 | 51 |
| 2013 | 38 | 43 |
| 2014 | 27 | 58 |
| 2015 | 38 | 62 |
| 2016 | 55 | 84 |
| 2017 | 57 | 69 |
| 2018 | 44 | 75 |
| 2019 | 65 | 101 |
| 2020 | 57 | 92 |
| 2021 | 63 | 129 |
| 2022 | 60 | 123 |
| 2023 | 73 | 89 |
| 2024 | 67 | 120 |
| 2025 | 60 | 83 |
| 2026 | 31 | 80 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2795/10011Dsdna bacteriophagesIndexing code565
- C12N 2795/14011Ssdna bacteriophagesIndexing code183
- C12N 2795/00032Use of virus as therapeutic agent, other than vaccineIndexing code149
- C12N 2795/18011Ssrna bacteriophages positive-senseIndexing code103
- C12N 2795/00021Viruses as suchIndexing code98
- C12N 2795/00041Use of virus, viral particle or viral elements as a vectorIndexing code73
- C12N 2795/00022New viral proteins or individual genes, new structural or functional aspects ofIndexing code62
- C12N 2795/00031Uses of virus other than therapeutic or vaccineIndexing code62
All 17 subgroupsShow fewer
- C12N 2795/00051Methods of production or purification of viral materialIndexing code55
- C12N 2795/00034Use of virus or viral component as vaccineIndexing code33
- C12N 2795/00071Demonstrated in vivo effectIndexing code22
- C12N 2795/00023Virus like particles [vlp]Indexing code18
- C12N 2795/12011Dsrna bacteriophagesIndexing code12
- C12N 2795/00033Use of viral protein as therapeutic agent other than vaccineIndexing code11
- C12N 2795/00061Methods of inactivation or attenuationIndexing code7
- C12N 2795/16011Ssrna bacteriophages negative-senseIndexing code2
- C12N 2795/00088For redistributionIndexing code0
Recent patents
- Bacteriophage effective for controlling Salmonella typhimurium and its derived biofilm, and an antibacterial composition comprising the same6 Oct 2026US 12,751,982 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Therapeutic bacteriophages22 Sep 2026US 12,742,158 B2University of Leicester
- Multimeric proteins for detecting a carbohydrate and/or treating a siglec-mediated disorder25 Aug 2026US 12,715,903 B2Palleon Pharmaceuticals Inc.
- Methods and compositions for microbial delivery of double stranded RNA28 Jul 2026US 12,690,596 B2Rnaissance AG LLC
- Methods and systems for the rapid detection of Listeria using infectious agents28 Jul 2026US 12,692,482 B2Laboratory Corporation of America Holdings
- Methods and compositions for microbial delivery of double stranded rna8 Oct 2026US 2026/0305618 A1Rnaissance AG LLC
- Engineered bacteriophage particle and method of gene therapy by using same8 Oct 2026US 2026/0308626 A1Academia Sinica
- Programmable miRNA-Dependent Gene Expression1 Oct 2026US 2026/0295089 A1New York University
- Bacteriophage vb_sbrt-pbovineb21 having lytic activity and biofilm control activity against streptococcus bovis/streptococcus equinus complex and lactic acid-producing bacteria1 Oct 2026US 2026/0297541 A1Gachon University of Industry-Academic Cooperation Foundation
- Prolactin Receptor Antibody and Use Thereof24 Sep 2026US 2026/0285993 A1
Most cited
By later US patents
- Directed evolution of novel binding proteins2,450US 5,223,409 AProtein Engineering Corporation · 1993
- Viruses expressing chimeric binding proteins1,136US 5,403,484 AProtein Engineering Corporation · 1995
- Directed evolution of novel binding proteins1,057US 5,571,698 AProtein Engineering Corporation · 1996
- Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants660US 5,750,373 AGenentech, Inc. · 1998
- Surface expression libraries of heteromeric receptors586US 5,698,426 AIxsys, Inc. · 1997